{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:31:11Z","timestamp":1777073471613,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/00100\/2020"],"award-info":[{"award-number":["UIDB\/00100\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04046\/2020"],"award-info":[{"award-number":["UIDB\/04046\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04046\/2020"],"award-info":[{"award-number":["UIDP\/04046\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["CEECIND\/00630\/2017"],"award-info":[{"award-number":["CEECIND\/00630\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["IF\/00069\/2014"],"award-info":[{"award-number":["IF\/00069\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/108031\/2015"],"award-info":[{"award-number":["SFRH\/BD\/108031\/2015"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e Tecnologia","doi-asserted-by":"publisher","award":["IF\/00069\/2014\/CP1216\/CT0006"],"award-info":[{"award-number":["IF\/00069\/2014\/CP1216\/CT0006"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biometals"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s10534-021-00325-w","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T04:31:30Z","timestamp":1624336290000},"page":"1029-1042","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Binding of RuCp complexes with human apo-transferrin: fluorescence spectroscopy and molecular docking methods"],"prefix":"10.1007","volume":"34","author":[{"given":"Filipa C.","family":"Santos","sequence":"first","affiliation":[]},{"given":"Paulo J.","family":"Costa","sequence":"additional","affiliation":[]},{"given":"M. Helena","family":"Garcia","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0233-8243","authenticated-orcid":false,"given":"T\u00e2nia S.","family":"Morais","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"325_CR1","doi-asserted-by":"publisher","first-page":"6158","DOI":"10.1063\/1.478522","volume":"110","author":"C Adamo","year":"1999","unstructured":"Adamo C, Barone V (1999) Toward reliable density functional methods without adjustable parameters: the PBE0 model. J Chem Phys 110:6158\u20136170. https:\/\/doi.org\/10.1063\/1.478522","journal-title":"J Chem Phys"},{"key":"325_CR2","first-page":"1","volume-title":"Encycl Inorg Bioinorg Chem","author":"M Adams","year":"2017","unstructured":"Adams M, Hanif M, Hartinger CG (2017) Ruthenium anticancer agents-from cisplatin analogues to rational drug design. Encycl Inorg Bioinorg Chem. John Wiley & Sons, Ltd, Chichester, pp 1\u201321"},{"key":"325_CR3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cca.2014.05.004","volume":"436","author":"MJ Akhtar","year":"2014","unstructured":"Akhtar MJ, Ahamed M, Alhadlaq HA et al (2014) Targeted anticancer therapy: overexpressed receptors and nanotechnology. Clin Chim Acta 436:78\u201392","journal-title":"Clin Chim Acta"},{"key":"325_CR4","doi-asserted-by":"publisher","first-page":"975756","DOI":"10.1155\/2010\/975756","volume":"2010","author":"FA Beckford","year":"2010","unstructured":"Beckford FA (2010) Reaction of the anticancer organometallic ruthenium compound,[(h6-p-cymene)Ru(ATSC)Cl] with human serum albumin. Int J Inorg Chem 2010:975756. https:\/\/doi.org\/10.1155\/2010\/975756","journal-title":"Int J Inorg Chem"},{"key":"325_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1039\/c1mt00003a","volume":"3","author":"F Beckford","year":"2011","unstructured":"Beckford F, Thessing J, Woods J et al (2011) Synthesis and structure of [(\u03b76-p-cymene)Ru(2-anthracen-9- ylmethylene-N-ethylhydrazinecarbothioamide)Cl]Cl: biological evaluation, topoisomerase II inhibition and reaction with DNA and human serum albumin. Metallomics 3:491\u2013502. https:\/\/doi.org\/10.1039\/c1mt00003a","journal-title":"Metallomics"},{"key":"325_CR6","volume-title":"Amber 2015","author":"DA Case","year":"2015","unstructured":"Case DA, Berryman JT, Betz RM et al (2015) Amber 2015. University of California, San Francisco"},{"key":"325_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.jinorgbio.2007.11.003","volume":"102","author":"A Casini","year":"2008","unstructured":"Casini A, Hartinger C, Gabbiani C et al (2008) Gold(III) compounds as anticancer agents: relevance of gold\u2013protein interactions for their mechanism of action. J Inorg Biochem 102:564\u2013575. https:\/\/doi.org\/10.1016\/j.jinorgbio.2007.11.003","journal-title":"J Inorg Biochem"},{"key":"325_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ica.2013.04.023","volume":"404","author":"D Chatterjee","year":"2013","unstructured":"Chatterjee D, Bose KJC, Mukhopadhyay S (2013) Binding of aquo-ethylenediaminetetraacetatoruthenium(III) to apo-transferrin. Fluorescence, antiproliferative and in silico studies. Inorg Chim Acta 404:1\u20134. https:\/\/doi.org\/10.1016\/j.ica.2013.04.023","journal-title":"Inorg Chim Acta"},{"key":"325_CR9","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1017\/S143192761300175X","volume":"19","author":"L C\u00f4rte-Real","year":"2013","unstructured":"C\u00f4rte-Real L, Matos AP, Alho I et al (2013) Cellular uptake mechanisms of an antitumor ruthenium compound: The endosomal\/lysosomal system as a target for anticancer metal-based drugs. Microsc Microanal 19:1122\u20131130. https:\/\/doi.org\/10.1017\/S143192761300175X","journal-title":"Microsc Microanal"},{"key":"325_CR10","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00775-014-1120-y","volume":"19","author":"L C\u00f4rte-Real","year":"2014","unstructured":"C\u00f4rte-Real L, Mendes F, Coimbra J et al (2014) Anticancer activity of structurally related ruthenium (II) cyclopentadienyl complexes. J Biol Inorg Chem 19:853\u2013867. https:\/\/doi.org\/10.1007\/s00775-014-1120-y","journal-title":"J Biol Inorg Chem"},{"key":"325_CR11","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.2174\/092986710793213742","volume":"17","author":"J Costa Pessoa","year":"2010","unstructured":"Costa Pessoa J, Tomaz I (2010) Transport of therapeutic vanadium and ruthenium complexes by blood plasma components. Curr Med Chem 17:3701\u20133738. https:\/\/doi.org\/10.2174\/092986710793213742","journal-title":"Curr Med Chem"},{"key":"325_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1021\/ed070p425","volume":"70","author":"A Coutinho","year":"1993","unstructured":"Coutinho A, Prieto M (1993) Ribonuclease T1 and alcohol dehydrogenase fluorescence quenching by acrylamide\u2014a laboratory experiment for undergraduate students. J Chem Educ 70:425\u2013428. https:\/\/doi.org\/10.1021\/ed070p425","journal-title":"J Chem Educ"},{"key":"325_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/inorganics7030031","volume":"7","author":"JPC Coverdale","year":"2019","unstructured":"Coverdale JPC, Laroiya-McCarron T, Romero-Canel\u00f3n I (2019) Designing ruthenium anticancer drugs: what have we learnt from the key drug candidates? Inorganics 7:31","journal-title":"Inorganics"},{"key":"325_CR14","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/j.jlumin.2011.06.005","volume":"131","author":"F Ding","year":"2011","unstructured":"Ding F, Diao JX, Yang XL, Sun Y (2011) Structural analysis and binding domain of albumin complexes with natural dietary supplement humic acid. J Lumin 131:2244\u20132251. https:\/\/doi.org\/10.1016\/j.jlumin.2011.06.005","journal-title":"J Lumin"},{"key":"325_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1080\/15216540500404093","volume":"57","author":"M Fasano","year":"2005","unstructured":"Fasano M, Curry S, Terreno E et al (2005) The extraordinary ligand binding properties of human serum albumin. IUBMB Life 57:787\u2013796","journal-title":"IUBMB Life"},{"key":"325_CR16","doi-asserted-by":"publisher","first-page":"11926","DOI":"10.1039\/c6dt01571a","volume":"45","author":"PR Florindo","year":"2016","unstructured":"Florindo PR, Pereira DM, Borralho PM et al (2016) New [ (\u03b75-C5H5)Ru (N-N) (PPh3)][PF6] compounds: Colon anticancer activity and GLUT-mediated cellular uptake of carbohydrate-appended complexes. Dalt Trans 45:11926\u201311930. https:\/\/doi.org\/10.1039\/c6dt01571a","journal-title":"Dalt Trans"},{"key":"325_CR17","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1039\/d0dt00955e","volume":"49","author":"J Franco Machado","year":"2020","unstructured":"Franco Machado J, Machuqueiro M, Marques F et al (2020) Novel \u201cruthenium cyclopentadienyl\u201d-peptide conjugate complexes against human FGFR (+) breast cancer. Dalt Trans 49:5974\u20135987. https:\/\/doi.org\/10.1039\/d0dt00955e","journal-title":"Dalt Trans"},{"key":"325_CR18","unstructured":"Frisch MJ, Trucks GW, Schlegel HB et al (2016) Gaussian 09 Revision D.01. Gaussian 09 Revis. D.01. Gaussian Inc. Wallingford"},{"key":"325_CR19","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.2174\/1871520619666190318152726","volume":"19","author":"L Gano","year":"2019","unstructured":"Gano L, Pinheiro T, Matos AP et al (2019) Antitumour and toxicity evaluation of a Ru(II)-cyclopentadienyl complex in a prostate cancer model by imaging tools. Anticancer Agents Med Chem 19:1262\u20131275. https:\/\/doi.org\/10.2174\/1871520619666190318152726","journal-title":"Anticancer Agents Med Chem"},{"key":"325_CR20","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1021\/jm061081y","volume":"50","author":"M Groessl","year":"2007","unstructured":"Groessl M, Reisner E, Hartinger CG et al (2007) Structure\u2013activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiproliferative activity. J Med Chem 50:2185\u20132193. https:\/\/doi.org\/10.1021\/jm061081y","journal-title":"J Med Chem"},{"key":"325_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jmgm.2017.05.005","volume":"75","author":"JR G\u00fcette-Fern\u00e1ndez","year":"2017","unstructured":"G\u00fcette-Fern\u00e1ndez JR, Mel\u00e9ndez E, Maldonado-Rojas W et al (2017) A molecular docking study of the interactions between human transferrin and seven metallocene dichlorides. J Mol Graph Model 75:250\u2013265. https:\/\/doi.org\/10.1016\/j.jmgm.2017.05.005","journal-title":"J Mol Graph Model"},{"key":"325_CR22","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0010-8545(02)00037-1","volume":"228","author":"WR Harris","year":"2002","unstructured":"Harris WR, Messori L (2002) A comparative study of aluminum (III), gallium (III), indium (III), and thallium (III) binding to human serum transferrin. Coord Chem Rev 228:237\u2013262","journal-title":"Coord Chem Rev"},{"key":"325_CR23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jinorgbio.2006.02.013","volume":"100","author":"CG Hartinger","year":"2006","unstructured":"Hartinger CG, Zorbas-Seifried S, Jakupec MA et al (2006) From bench to bedside\u2014preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A). J Inorg Biochem 100:891\u2013904","journal-title":"J Inorg Biochem"},{"key":"325_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijbiomac.2005.09.007","volume":"37","author":"YJ Hu","year":"2005","unstructured":"Hu YJ, Liu Y, Zhao RM, Qu SS (2005) Interaction of colchicine with human serum albumin investigated by spectroscopic methods. Int J Biol Macromol 37:122\u2013126. https:\/\/doi.org\/10.1016\/j.ijbiomac.2005.09.007","journal-title":"Int J Biol Macromol"},{"key":"325_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1152\/physrev.1987.67.2.520","volume":"67","author":"HA Huebers","year":"1987","unstructured":"Huebers HA, Finch CA (1987) The physiology of transferrin and transferrin receptors. Physiol Rev 67:520\u2013582","journal-title":"Physiol Rev"},{"key":"325_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1039\/AN9941900417","volume":"119","author":"M Kubista","year":"1994","unstructured":"Kubista M, Sj\u00f6back R, Eriksson S, Albinsson B (1994) Experimental correction for the inner-filter effect in fluorescence spectra. Analyst 119:417\u2013419. https:\/\/doi.org\/10.1039\/AN9941900417","journal-title":"Analyst"},{"key":"325_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-46312-4","volume-title":"Principles of fluorescence spectroscopy","author":"JR Lakowicz","year":"2006","unstructured":"Lakowicz JR (2006) Principles of fluorescence spectroscopy. Springer, New York"},{"key":"325_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.biophys.29.1.1","volume":"29","author":"D Leckband","year":"2000","unstructured":"Leckband D (2000) Measuring the forces that control protein interactions. Annu Rev Biophys Biomol Struct 29:1\u201326","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"325_CR29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/med.10008","volume":"22","author":"H Li","year":"2002","unstructured":"Li H, Qian ZM (2002) Transferrin\/transferrin receptor-mediated drug delivery. Med Res Rev 22:225\u2013250","journal-title":"Med Res Rev"},{"key":"325_CR30","doi-asserted-by":"publisher","unstructured":"Lin K, Zhao ZZ, Bo H, Ben et al (2018) Applications of ruthenium complex in tumor diagnosis and therapy. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2018.01323","DOI":"10.3389\/fphar.2018.01323"},{"key":"325_CR31","doi-asserted-by":"publisher","first-page":"9904","DOI":"10.1039\/c9cc04098f","volume":"55","author":"J Liu","year":"2019","unstructured":"Liu J, Lai H, Xiong Z et al (2019) Functionalization and cancer-targeting design of ruthenium complexes for precise cancer therapy. Chem Commun 55:9904\u20139914. https:\/\/doi.org\/10.1039\/c9cc04098f","journal-title":"Chem Commun"},{"key":"325_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jinorgbio.2012.07.017","volume":"116","author":"O Mazuryk","year":"2012","unstructured":"Mazuryk O, Kurpiewska K, Lewi\u0144ski K et al (2012) Interaction of apo-transferrin with anticancer ruthenium complexes NAMI-A and its reduced form. J Inorg Biochem 116:11\u201318. https:\/\/doi.org\/10.1016\/j.jinorgbio.2012.07.017","journal-title":"J Inorg Biochem"},{"key":"325_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1871520616666160922165133","volume":"16","author":"N Mendes","year":"2016","unstructured":"Mendes N, Tortosa F, Valente A et al (2016) In vivo performance of a ruthenium-cyclopentadienyl compound in an orthotopic 1 triple negative breast cancer model. Anticancer Agents Med Chem 16:1\u20131. https:\/\/doi.org\/10.2174\/1871520616666160922165133","journal-title":"Anticancer Agents Med Chem"},{"key":"325_CR34","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ccr.2016.08.001","volume":"326","author":"A Merlino","year":"2016","unstructured":"Merlino A (2016) Interactions between proteins and Ru compounds of medicinal interest: a structural perspective. Coord Chem Rev 326:111\u2013134","journal-title":"Coord Chem Rev"},{"key":"325_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jinorgbio.2013.01.011","volume":"122","author":"TS Morais","year":"2013","unstructured":"Morais TS, Santos F, C\u00f4rte-Real L et al (2013) Biological activity and cellular uptake of [Ru (\u03b75-C 5H5) (PPh3) (Me2bpy)][CF 3SO3] complex. J Inorg Biochem 122:8\u201317. https:\/\/doi.org\/10.1016\/j.jinorgbio.2013.01.011","journal-title":"J Inorg Biochem"},{"key":"325_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jinorgbio.2013.09.013","volume":"130","author":"TS Morais","year":"2014","unstructured":"Morais TS, Santos FC, Jorge TF et al (2014) New water-soluble ruthenium(II) cytotoxic complex: biological activity and cellular distribution. J Inorg Biochem 130:1\u201314. https:\/\/doi.org\/10.1016\/j.jinorgbio.2013.09.013","journal-title":"J Inorg Biochem"},{"key":"325_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4155\/fmc.16.7","volume":"8","author":"TS Morais","year":"2016","unstructured":"Morais TS, Valente A, Tomaz AI et al (2016) Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds. Future Med Chem 8:527\u2013544. https:\/\/doi.org\/10.4155\/fmc.16.7","journal-title":"Future Med Chem"},{"key":"325_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jinorgbio.2010.10.009","volume":"105","author":"V Moreno","year":"2011","unstructured":"Moreno V, Font-Bardia M, Calvet T et al (2011) DNA interaction and cytotoxicity studies of new ruthenium (II) cyclopentadienyl derivative complexes containing heteroaromatic ligands. J Inorg Biochem 105:241\u2013249. https:\/\/doi.org\/10.1016\/j.jinorgbio.2010.10.009","journal-title":"J Inorg Biochem"},{"key":"325_CR39","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W et al (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30:2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"key":"325_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.arabjc.2016.07.021","volume":"11","author":"M Ni\u0161avi\u0107","year":"2018","unstructured":"Ni\u0161avi\u0107 M, Stoiljkovi\u0107 M, Crnolatac I et al (2018) Highly water-soluble ruthenium (II) terpyridine coordination compounds form stable adducts with blood-borne metal transporting proteins. Arab J Chem 11:291\u2013304. https:\/\/doi.org\/10.1016\/j.arabjc.2016.07.021","journal-title":"Arab J Chem"},{"key":"325_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.aca.2013.05.004","volume":"785","author":"K Ossipov","year":"2013","unstructured":"Ossipov K, Foteeva LS, Seregina IF et al (2013) Metallomics for drug development: Serum protein binding and analysis of an anticancer tris (8-quinolinolato)gallium (III) drug using inductively coupled plasma mass spectrometry. Anal Chim Acta 785:22\u201326. https:\/\/doi.org\/10.1016\/j.aca.2013.05.004","journal-title":"Anal Chim Acta"},{"key":"325_CR42","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1039\/b309160k","volume":"19","author":"M Pongratz","year":"2004","unstructured":"Pongratz M, Schluga P, Jakupec MA et al (2004) Transferrin binding and transferrin-mediated cellular uptake of the ruthenium coordination compound KP1019, studied by means of AAS, ESI-MS and CD spectroscopy. J Anal At Spectrom 19:46\u201351. https:\/\/doi.org\/10.1039\/b309160k","journal-title":"J Anal At Spectrom"},{"key":"325_CR43","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1124\/pr.54.4.561","volume":"54","author":"ZM Qian","year":"2002","unstructured":"Qian ZM, Li H, Sun H, Ho K (2002) Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol Rev 54:561\u2013587","journal-title":"Pharmacol Rev"},{"key":"325_CR44","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1021\/ct8000409","volume":"4","author":"LE Roy","year":"2008","unstructured":"Roy LE, Hay PJ, Martin RL (2008) Revised basis sets for the LANL effective core potentials. J Chem Theory Comput 4:1029\u20131031. https:\/\/doi.org\/10.1021\/ct8000409","journal-title":"J Chem Theory Comput"},{"key":"325_CR45","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/nar\/gkv315","volume":"43","author":"S Salentin","year":"2015","unstructured":"Salentin S, Schreiber S, Haupt VJ et al (2015) PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res 43:443\u2013447. https:\/\/doi.org\/10.1093\/nar\/gkv315","journal-title":"Nucleic Acids Res"},{"key":"325_CR46","first-page":"57","volume":"17","author":"MF Sanner","year":"1999","unstructured":"Sanner MF (1999) Python: a programming language for software integration and development. J Mol Graph Model 17:57\u201361","journal-title":"J Mol Graph Model"},{"key":"325_CR47","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ijbiomac.2010.08.002","volume":"47","author":"S Sarzehi","year":"2010","unstructured":"Sarzehi S, Chamani J (2010) Investigation on the interaction between tamoxifen and human holo-transferrin: determination of the binding mechanism by fluorescence quenching, resonance light scattering and circular dichroism methods. Int J Biol Macromol 47:558\u2013569. https:\/\/doi.org\/10.1016\/j.ijbiomac.2010.08.002","journal-title":"Int J Biol Macromol"},{"key":"325_CR48","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ijbiomac.2010.08.002","volume":"47","author":"S Sarzehi","year":"2010","unstructured":"Sarzehi S, Chamani J (2010) Investigation on the interaction between tamoxifen and human holo-transferrin: determination of the binding mechanism by fluorescence quenching, resonance light scattering and circular dichroism methods. Int J Biol Macromol 47:558\u2013569. https:\/\/doi.org\/10.1016\/j.ijbiomac.2010.08.002","journal-title":"Int J Biol Macromol"},{"key":"325_CR49","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/BF00265663","volume":"15","author":"GJ Seymour","year":"1987","unstructured":"Seymour GJ, Walsh MD, Lavin MF et al (1987) Transferrin receptor expression by human bladder transitional cell carcinomas. Urol Res 15:341\u2013344. https:\/\/doi.org\/10.1007\/BF00265663","journal-title":"Urol Res"},{"key":"325_CR50","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/cr040704h","volume":"106","author":"AR Timerbaev","year":"2006","unstructured":"Timerbaev AR, Hartinger CG, Aleksenko SS, Keppler BK (2006) Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology. Chem Rev 106:2224\u20132248","journal-title":"Chem Rev"},{"key":"325_CR51","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1021\/cr9904009","volume":"105","author":"J Tomasi","year":"2005","unstructured":"Tomasi J, Mennucci B, Cammi R (2005) Quantum mechanical continuum solvation models. Chem Rev 105:2999\u20133093","journal-title":"Chem Rev"},{"key":"325_CR52","doi-asserted-by":"crossref","unstructured":"Tomaz AI, Jakusch T, Morais TS et al (2012) [RuII (\u03b75-C5H5 (bipy) (PPh3)]+, a promising large spectrum antitumor agent: cytotoxic activity and interaction with human serum albumin. J Inorg Biochem 117:261\u20139","DOI":"10.1016\/j.jinorgbio.2012.06.016"},{"key":"325_CR53","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334","author":"O Trott","year":"2009","unstructured":"Trott O, Olson AJ (2009) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31:NA-NA. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"key":"325_CR54","volume-title":"Molecular fluorescence: principles and applications","author":"B Valeur","year":"2013","unstructured":"Valeur B, Berberan-Santos MN (2013) Molecular fluorescence: principles and applications. Wiley, New York"},{"key":"325_CR55","doi-asserted-by":"publisher","first-page":"24934","DOI":"10.1074\/jbc.M604592200","volume":"281","author":"J Wally","year":"2006","unstructured":"Wally J, Halbrooks PJ, Vonrhein C et al (2006) The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding. J Biol Chem 281:24934\u201324944. https:\/\/doi.org\/10.1074\/jbc.M604592200","journal-title":"J Biol Chem"},{"key":"325_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jphotobiol.2014.08.020","volume":"141","author":"YQ Wang","year":"2014","unstructured":"Wang YQ, Zhang HM, Cao J (2014) Binding of hydroxylated single-walled carbon nanotubes to two hemoproteins, hemoglobin and myoglobin. J Photochem Photobiol B Biol 141:26\u201335. https:\/\/doi.org\/10.1016\/j.jphotobiol.2014.08.020","journal-title":"J Photochem Photobiol B Biol"},{"key":"325_CR57","doi-asserted-by":"publisher","first-page":"9006","DOI":"10.1021\/ic061008y","volume":"45","author":"HA Wee","year":"2006","unstructured":"Wee HA, Daldini E, Scolaro C et al (2006) Development of organometallic ruthenium-arene anticancer drugs that resist hydrolysis. Inorg Chem 45:9006\u20139013. https:\/\/doi.org\/10.1021\/ic061008y","journal-title":"Inorg Chem"}],"container-title":["BioMetals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-021-00325-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10534-021-00325-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10534-021-00325-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T16:17:42Z","timestamp":1631809062000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10534-021-00325-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["325"],"URL":"https:\/\/doi.org\/10.1007\/s10534-021-00325-w","relation":{},"ISSN":["0966-0844","1572-8773"],"issn-type":[{"value":"0966-0844","type":"print"},{"value":"1572-8773","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"13 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}